Ambio is an API manufacturer based in United States. It holds 6 active US drug master files across a filed portfolio of 6 molecules.
| Site | FDA FEI |
|---|---|
| Grovetown, United States | 3010755363 |
| Molecule | Regulators | Docs |
|---|---|---|
| Glatiramer | US FDA | 1 |
| Icatibant | US FDA | 1 |
| Liraglutide | US FDA | 1 |
| Semaglutide | US FDA | 1 |
| Teduglutide | US FDA | 1 |
| Teriparatide | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MPA (SE) | 1 | None |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Ambio comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.